ADAMANT: a placebo-controlled randomized phase 2 study of AADvac1, an active immunotherapy against pathological tau in Alzheimer’s disease

Petr Novák, Branislav Kováčech, Stanislav Katina, Reinhold Schmidt, Philip Scheltens, Eva Kontseková, Stefan Ropele, Ľubica Fialová, Milica G. Kramberger, Natalia Paulenka-Ivanovova, M Smísek, Jozef Hanes, Eva Stevens, Andrej Kováč, Stanislav Šutovský, Vojtech Parrák, Peter Koson, Michal Prčina, Jaroslav Galba, Martin Cente, Tomáš Hromádka, Peter Filipčík, Juraj Piešťanský, Maria Samcova, Carmen Prenn-Gologranc, Roman Sivak, Lutz Froelich, Michal Fresser, Martin Rakuša, John Harrison, Jakub Hort, Markus Otto, Duygu Tosun, Matej Ondrus, Bengt Winblad, Michal Novák, Norbert Žilka